From: A novel sialyl LeX expression score as a potential prognostic tool in colorectal cancer
 | Patients | n (%) |
---|---|---|
Patients | 215 | (100) |
Mean age (years) | 67.4 | |
Gender ratio (f/m) | 1:1.26 | (95:120) |
Rectal cancer patients | 73 | (34.0) |
Neoadjuvant radiochemotherapy | 7 | (9.6) |
Colon and rectal cancer patients UICC stage III | 113 | (52.6) |
Adjuvant (radio-) chemotherapy | 89 | (78.8) |
Colon and rectal cancer patients UICC stage IV | 102 | (47.4) |
Palliative (radio-) chemotherapy | 62 | (60.8) |
Tumor location | Â | Â |
Right hemicolon | 62 | (43.7) |
Transverse colon | 18 | (12.7) |
Left hemicolon | 6 | (4.2) |
Sigmoid colon | 56 | (39.4) |
Rectum | 73 | (34.0) |